Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 4, 2013, Pages

  Ohlsson, Arne ^a   Walia, Rajneesh ^b   Shah, Sachin S ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Aditya Birla Memorial Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INDOMETACIN; PLACEBO;

ARTIFICIAL VENTILATION; CREATININE BLOOD LEVEL; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFANT; INTESTINE PERFORATION; KIDNEY FAILURE; LOW BIRTH WEIGHT; LUNG HEMORRHAGE; NECROTIZING ENTEROCOLITIS; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT FAILURE;

EID: 84886842665     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003481.pub5     Document Type: Review

References (87)

1. Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A. Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants [Porownanie ibuprofenu i indometacyny w leczeniu przetrwalego przewodu tetniczego u noworodkow urodzonych przedwczesnie]. Medycyna Wieku Rozwojowego 2005;9:335-54.
2. Akisu M, Ozyurek AR, Dorak C, Parlar A, Kultursay N. Enteral ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm newborn infants [Premature bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazinin etkinligi ve guvenilirligi]. Cocuk Sagligi ve Hastaliklari Dergisi 2001;44:56-60.
3. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. American Journal of Perinatology 2007;24(5):267-70.
4. Lotfy W, Badrawi N, Ghawas M, Ehsan E, Aly H. Oral ibuprofen solution (O) is efficacious for the treatment of patent ductus arteriosus (PDA) in premature infants: A randomized controlled trial. Pedaitric Academic Societies Annual Meeting http://www.abstracts2view.com. PAS2005:1410.
5. Aranda JV. Multicentre randomized double-blind placebo controlled trial of ibuprofen L-Lysine intravenous solution (IV Ibuprofen) in premature infants for the early treatment of patent ductus arteriosus (PDA). Pedaitric Academic Societies Annual Meeting http://www.abstracts2view.com. PAS2005.
6. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, et al.A randomized, double-blind, placebo-controlled trial of intravenous ibuprofen L-lysine for the early closure of non-symptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. American Journal of Perinatology 2009;26(3):235-45.
7. Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara M, Guellouze N, et al.Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 2008;122(6):e1256-61.
8. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. Journal of Medical Association of Thailand 2003;86(Suppl 3):S563-9.
9. Dani C, Vangi V, Bertini G, Pratesi S, Lori I, Favelli F, et al.High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: A randomized controlled study. Clinical Pharmacology and Therapeutics 2012;91(4):590-6.
10. Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, et al.Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Archives of Diseases in Childhood, Fetal and Neonatal Edition 2012;97(4):F279-83.
11. Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Chinese Journal of Contemporary Pediatrics 2007;9(5):399-403.
12. Gimeno Navarro A, Cano Sanchez A, Fernandez Gilino C, Carrasco Moreno JI, Izquierdo Macian I, Gutierrez Laso A, et al.Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants [Ibuprofeno frente a indometacina en el tratamiento del conducto arterioso persistente del prematuro]. Anales de Pediatria 2005;63(3):212-8.
13. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral verus intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Journal of Pediatrics 2011;158(4):549-54.
14. Hammerman C, Shchors I, Jacobson S, Schimmel MS, Bromiker R, Kaplan M, et al.Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration?. Pediatric Research 2008;64(3):291-7.
15. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al.Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. European Journal of Pediatrics 2002;161(4):202-7.
16. Lago P, Salvadori S, Bettiol T, Pitassi I, Chiandetti L, Saia OS. Effects of indomethacin and ibuprofen on renal function in preterm infants treated for patent ductus arteriosus: A randomized controlled trial. Pediatric Research 2001;49:375A.
17. Zanardo V, Vedovato S, Lago P, Piva D, Faggian D, Chiozza L. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus. Fetal Diagnosis and Therapy 2005;20(6):534-9.
18. Lin XZ, Chen HQ, Zheng Z, Li YD, Lai JD, Huang LH. Therapeutic effect of early administration of oral ibuprofen in very low birth weight infants with patent ductus arteriosus. Zhongguo dang dai er ke za zhi (Chinese Journal of Contemporary Pediatrics) 2012;14(7):502-5.
19. Mosca F, Bray M, Lattanzio M, Fumagalli M, Colnaghi M, Castoldi F, et al.Comparison of the effects of ibuprofen and indomethacin on PDA closure and cerebral perfusion and oxygenation. Pediatric Research 1997;41:165A.
20. Mosca F, Bray M, Lattanzio M, Fumagalli M, Colnaghi MR, Compagnoni G. Comparison of the effects of indomethacin (INDO) and ibuprofen (IBU) on cerebral perfusion and oxygenation in preterm infants. Pediatric Research 1996;39:231A.
21. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1997;131(4):549-54.
22. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995;346(8969):255.
23. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatric Research 2000;47(1):36-42.
24. Pezzati M, Bertini G, Vangi V, Biagiotti R, Cianciulli D, Rubaltelli FF. Mesenteric and renal perfusion in preterm infants with PDA: Indomethacin vs ibuprofen (Abstract). Pediatric Research 1999;45:218A.
25. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubatelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1999;135(6):733-8.
26. Plavka R, Svihovec P, Borek I, Biolek J, Kostirova M, Liska K, et al.Ibuprofen vs. indomethacin in the treatment of patent ductus arteriosus (PDA) in very premature neonates. Pediatric Research 2001;49:375A.
27. Pourarian Sh, Pishva N, Madani A, Rastegari M. Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants. Eastern Mediterranean Health Journal 2008;14(2):360-5.
28. Salama H, Alsisi A, Al-Rifai H, Shaddad A, Samawal L, Habboub L, et al.A randomized controlled trial on the use of oral ibuprofen to close patent ductus arteriosus in premature infants. Journal of Neonatal-Perinatal Medicine 2008;1(3):153-8.
29. Sosenko IR, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. Journal of Pediatrics 2012;160(6):929-35.
30. Su P-H, Chen J-Y, Su C-M, Huang T-C, Lee H-S. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatrics International 2003;45(6):665-70.
31. Su B-H, Lin H-C, Chiu H-Y, Hsieh H-Y, Chen H-H, Tsai Y-C. Comparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Archives of Disease in Childhood. Fetal and Neonatal Edition 2008;93(2):F94-9.
32. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi hospital. Journal of Medical Association of Thailand 2002;85(Suppl 4):S1252-8.
33. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Archives of Disease in Childhood. Fetal and Neonatal Edition 1997;76(3):F179-84.
34. Van Overmeire B, Follens I, Hartmann S, Mahieu L, Van Reempts PJ. Intravenous ibuprofen (IBU) for the treatment of patent ductus arteriosus (PDA) in preterm infants with respiratory distress syndrome (RDS). Pediatric Research 1996;39:250A.
35. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1999;135(6):733-8.
36. Van Overmeire B, Langhendries JP, Vanhaesebrouck P, Lecoutere D, Van de Broek. Ibuprofen for early treatment of patent ductus arteriosus, a randomized multicentre trial. Pediatric Research 1998;43:200A.
37. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, De Groote K, et al.A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. New England Journal of Medicine 2000;343(10):674-81.
38. Amoozgar H, Ghodstehrani M, Pishva N. Oral ibuprofen and ductus arteriosus closure in full-term neonates: a prospective case-control study. Pediatric Cardiology 2010;31(1):40-3.
39. Cherif A, Jabnoun S, Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. American Journal of Perinatology 2007;24(6):339-45.
40. Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, et al.Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. Journal of Clinical Pharmacy & Therpeutics 2005;30(2):121-32.
41. Fesharaki HJ, Nayeri FS, Asbaq PA, Amini E, Sedagat M. Different doses of ibuprofen in the treatment of patent ductus arteriosus: a randomized controlled trial. Tehran University Medical Journal 2012;70(8):488-93.
42. Qosja A, Kuneshka N, Tushe E, Teneqexhi L. Oral versus intravenous ibuprofen for patent ductus arteriosus closure. Giornale Italiano di Cardiologia. 42nd Congresso Nazionale della Societa Italiana di Cardiologia Pediatrica, Jesi, Italy. 2012:15S-16S.
43. Gournay V. Early ibuprofen treatment of patent ductus arteriosus (PDA) in premature infants (TRIOCAPI). ClinicalTrials.gov. NCT01630278. ClinicalTrials.gov, 2012.
44. Su B-H. Comparison of oral and intravenous ibuprofen for PDA treatment in premature infants. NCT01149564. ClinicalTrials.gov, 2010.
45. Amendolia B, Lynn M, Bhat V, Ritz SB, Aghai ZH. Severe pulmonary hypertension with therapeutic L-lysine ibuprofen in 2 preterm infants. Pediatrics 2012;129(5):e1360-3.
46. Bellini C, Campone F, Serra G. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. Canadian Medical Association Journal 2006;174(13):1843-4.
47. Chemtob S, Behary K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990;21(5):777-84.
48. Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV. Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatric Research 1991;30:106-11.
49. Coceani F, White E, Bodach E, Olley PM. Age-dependent changes in the responses of the lamb ductus arteriosus to oxygen and ibuprofen. Canadian Journal of Physiology and Pharmacology 1979;57:825-31.
50. Coceani F, Barogi S, Brizza F, Ackerley C, Seidlitz, Kelsey L, et al.Cyclooxygenase isoenzymes and patency of ductus arteriosus. Prostaglandins, Leukotrines and Essential Fatty Acids 2005;72:71-7.
51. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. Journal of Pediatrics 1978;93:647-51.
52. Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. Journal of Pediatrics 1979;2:467-73.
53. Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335(8704):1491-5.
54. Ellison RC, Pecham GJ, Lang P, Talner NS, Lerer TJ, Lin L, et al.Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983;71:364-72.
55. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: 10.1002/14651858.CD000174.pub2].
56. Gournay V, Savagner C, Thirez G, Kuster A, Roze J-C. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;359(9316):1486-8.
57. Grosfeld JL, Kamman K, Gross K, Cikrit D, Ross D, Wolfe M, et al.Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischaemia. Journal of Pediatric Surgery 1983;18(6):738-42.
58. Hardy P, Peri KG, Lahaie I, Varma DR, Chemtob S. Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs. Circulation Research 1996;79(3):504-11.
59. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
60. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5(Apr 20):13.
61. Ito K, Niida Y, Sato J, Owada E, Ito K, Umetsu M. Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus. Acta Paediatrica Japonica 1994;36(4):387-91.
62. Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J. Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatric Nephrology 1994;8(6):700-4.
63. Lee SK, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R, et al.Variations in practice and outcomes in the Canadian NICU Network 1996-1997. Pediatrics 2000;106(5):1070-9.
64. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very low birth weight infants. New England Journal of Medicine 1982;306(9):506-10.
65. Mathew R. Development of the pulmonary circulation: metabolic aspects. In: Polin RA, Fox WW editor(s). Fetal and Neonatal Physiology. Vol. 1, Philadelphia: W.B.Saunders Company, 1998:924-9.
66. Naulty CM, Horn S, Conry J, Avery GB. Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. Journal of Pediatrics 1978;93(4):682-4.
67. Neumann R, Schulzke SM, Bührer C. Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: A systematic review and meta-analysis. Neonatology 2012;102(1):9-15.
68. Niopas I, Mamzoridi K. Determination of indomethacin and mefenamic acid in plasma performance liquid chromatography. Journal of Chromatography. Biomedical Applications 1994;656(2):447-50.
69. Ohlsson A, Bottu J, Govan J, Ryan ML, Fong K, Myhr T. The effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with patent ductus arteriosus. Developmental Pharmacology and Therapeutics 1993;20(1-2):100-6.
70. Ohlsson A. Back to the drawing board. Pediatric Research 2000;47(1):4-5.
71. Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD004213.pub3].
72. Pellicer A, Aparicio M, Cabanas F, Valverde E, Quero J, Stiris TA. Effect of the cyclo-oxygenase blocker ibuprofen on cerebral blood volume and cerebral blood flow during normocarbia and hypercarbia in newborn piglets. Acta Pediatrica 1999;88(1):82-8.
73. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2011.
74. Sakhalkar VS, Merchant RH. Therapy of symptomatic patent ductus arteriosus in preterms with mefenemic acid and indomethacin. Indian Pediatrics 1992;29(3):313-8.
75. Schmidt B, Davis P, Moddeman D, Ohlsson A, Roberts RS, Saigal S, et al.Long-term effect of indomethacin prophylaxis in extremely-low-birth-weight infants. New England Journal of Medicine 2001;344(26):1966-72.
76. Sehgal A, Kumarshingri PS. Pulmonary hypertension in an infant treated with ibuprofen. Indian Journal of Pediatrics 2012;July 29:Epub ahead of print.
77. Seyberth HW, Rascher W, Hackenthal R, Wille L. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very low birth weight infants with symptomatic ductus arteriosus. Journal of Pediatrics 1983;103(6):979-84.
78. Stefano JL, Abbasi S, Pearlman SA, Spear ML, Esterly KL, Bhutani VK. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome; effects on pulmonary compliance and ventilation. American Review of Respiratory Disease 1991;143(2):236-9.
79. Uchiyama A, Nagasawa H, Yamamoto Y, Tatebayashi K, Suzuki H, Yamada K, et al.Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus. Pediatrics International 2011;53(3):322-7.
80. Van Overmeire B, Langhendries JP, Vanhasebrouck P, Lecoutere D, Van de Broek H. Ibuprofen for early treatment of patent ductus arteriosus, a randomized multicentre trial. Pediatric Research. 1998; Vol. 43:200A.
81. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275(7):539-44.
82. Weir FJ, Ohlsson A, Myhr TL, Fong K, Ryan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. European Journal of Pediatrics 1999;158(6):484-7.
83. Wolf WM, Snover DC, Leonard AS. Localized intestinal perforation following intravenous indomethacin in premature infants. Journal of Pediatric Surgery 1989;24(4):409-10.
84. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD003481].
85. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD003481.pub2].
86. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD003481.pub3].
87. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD003481.pub4].